1991
DOI: 10.7164/antibiotics.44.357
|View full text |Cite
|
Sign up to set email alerts
|

Novel avermectins produced by mutational biosynthesis.

Abstract: Avermectins with a wide range of novel C-25 substituents have been prepared by feeding carboxylic acids or their biosynthetic precursors to a Streptomyces avermitilis mutant strain ATCC 53568. This organism lacks the ability to form isobutyric and S-2-methylbutyric acids from their 2-oxo acid precursors and thus is unable to produce natural avermectins unless supplied with these acids. The novel avermectins produced by mutational biosynthesis possess broad-spectrum antiparasitic activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
98
0
3

Year Published

1995
1995
2012
2012

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 164 publications
(102 citation statements)
references
References 19 publications
(1 reference statement)
1
98
0
3
Order By: Relevance
“…5. The latter greatly facilitates the development of a larger selection of S. avermitilis bkd strains that can be used to generate valuable novel (unnatural) C-25-substituted antiparasitic avermectins (15).…”
Section: Vol 177 1995 S Avermitilis Bkdf Mutant and Avermectin Promentioning
confidence: 99%
See 1 more Smart Citation
“…5. The latter greatly facilitates the development of a larger selection of S. avermitilis bkd strains that can be used to generate valuable novel (unnatural) C-25-substituted antiparasitic avermectins (15).…”
Section: Vol 177 1995 S Avermitilis Bkdf Mutant and Avermectin Promentioning
confidence: 99%
“…The mutant could synthesize natural avermectins only when the ␣-branched-chain fatty acids or a precursor bearing the isopropyl or sec-butyl (S-form) group was added to the fermentation medium ( Fig. 1, bottom), while supplementation with a wide variety of alternative fatty acids results in the formation of a corresponding series of novel avermectins (15). These results are possible since short-chain fatty acids are readily taken up by S. avermitilis from the fermentation medium in a process that has been postulated to require at least a fatty acid binding and transport protein (probably similar to the Escherichia coli FadL protein) and a membrane-associated acylCoA synthetase (probably similar to the E. coli FadD protein) (17).…”
mentioning
confidence: 99%
“…The degradation products of these amino acids are isovaleryl-CoA, isobutyryl-CoA, and 2-methylbutyryl-CoA, respectively (12), which are used as starting units for iso-and anteiso-fatty acids and also for several secondary metabolites from different bacteria (e.g. avermectin from Streptomyces avermitilis (13) or myxothiazol (14), myxalamides (15), and aurafuron 2 The abbreviations used are: Bkd, branched-chain keto acid dehydrogenase; FA, fatty acid; SCFA, straight-chain fatty acid; FAME, fatty acid methyl ester; IVA, isovalerate; iso15:0, 13-methyltetradecanoate; MvaS, 3-hydroxy-3-methylglutaryl-CoA synthase; kan, kanamycin; PE, phosphatidylethanolamine; di-iso15:0-PE, 1,2-di-(-O-(13-methyltetradecanoyl)glycero-3-phosphatidylethanolamine; VEPE, 1-O-(13-methyl-1-Z-tetradecenyl)-2-O-(13-methyltetradecanoyl)glycero-3-phosphatidylethanolamine; AEPE, 1-O-(13-methyltetradecyl)-2-O-(13-methyltetradecanoyl)glycero-3-phosphatidylethanolamine; TG-1, 1,2-di-(13-methyltetradecanoyl)-3-(13-methyltetradecyl)glycerol; TG-2, 1,2-di-(hexadecanoyl)-3-(13-methyltetradecyl)glycerol; TPG, glycerol tripalmitate; GC, gas chromatography; MS, mass spectrometry; MS/MS, tandem mass spectrometry; HPLC, high performance liquid chromatography; ESI, electrospray ionization; PR, peripheral rod.…”
mentioning
confidence: 99%
“…Besides being important intermediates in the degradation of these abundant amino acids, the thioesters are important starting units in the biosynthesis of secondary metabolites and fatty acids (FAs). Well-known examples for IB-CoA-or 2MB-CoA-primed secondary metabolites are the avermectins (8), but there are also several secondary metabolites that use IV-CoA as a starting unit (e.g., myxothiazol [24] and aurafuron [15]). In FA biosynthesis, IV-CoA, IB-CoA, and 2MB-CoA are the starting units of iso-odd, iso-even, and ante-iso-odd FAs, respectively, which can be found in various bacteria and can substitute for unsaturated fatty acids to maintain membrane fluidity at different temperatures (12).…”
mentioning
confidence: 99%